<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1(4)</volume><submitter>Ding D</submitter><pubmed_abstract>We report the discovery of benzoxaborole antitrypanosomal agents and their structure-activity relationships on central linkage groups and different substitution patterns in the sulfur-linked series. The compounds showed in vitro growth inhibition IC50 values as low as 0.02 μg/mL and in vivo efficacy in acute murine infection models against Tryapnosoma brucei.</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pagination>165-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4007846</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovery of novel benzoxaborole-based potent antitrypanosomal agents.</pubmed_title><pmcid>PMC4007846</pmcid><pubmed_authors>Hernandez V</pubmed_authors><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Meng Q</pubmed_authors><pubmed_authors>Yarlett N</pubmed_authors><pubmed_authors>Ding D</pubmed_authors><pubmed_authors>Jacobs RT</pubmed_authors><pubmed_authors>Ang KH</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Nare B</pubmed_authors><pubmed_authors>Chen D</pubmed_authors><pubmed_authors>Xie D</pubmed_authors><pubmed_authors>Abdulla M</pubmed_authors><pubmed_authors>Zhang YK</pubmed_authors><pubmed_authors>McKerrow JH</pubmed_authors><pubmed_authors>Ratnam J</pubmed_authors><pubmed_authors>Freund Y</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Bacchi CJ</pubmed_authors><pubmed_authors>Plattner JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery of novel benzoxaborole-based potent antitrypanosomal agents.</name><description>We report the discovery of benzoxaborole antitrypanosomal agents and their structure-activity relationships on central linkage groups and different substitution patterns in the sulfur-linked series. The compounds showed in vitro growth inhibition IC50 values as low as 0.02 μg/mL and in vivo efficacy in acute murine infection models against Tryapnosoma brucei.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Jul</publication><modification>2025-04-05T10:37:18.713Z</modification><creation>2019-03-27T01:27:29Z</creation></dates><accession>S-EPMC4007846</accession><cross_references><pubmed>24900190</pubmed><doi>10.1021/ml100013s</doi></cross_references></HashMap>